|
|
Article: FDA Approves Re-Formulated CLARINEX(R) (desloratadine) REDITABS(R) Tablets - Orally Disintegrating Prescription Antihistamine.
- Article from:
- PR Newswire
- Article date:
- July 15, 2005
CopyrightCOPYRIGHT 2005 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
REDITAB Dissolves Without Water to Treat Indoor and Outdoor Allergies and Hives of Unknown Cause
KENILWORTH, N.J., July 15 /PRNewswire-FirstCall/ -- Schering-Plough Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved re-formulated CLARINEX(R) (desloratadine 2.5 mg and 5 mg) REDITABS(R) tablets for the treatment of allergy symptoms caused by both perennial indoor and seasonal outdoor allergens and chronic idiopathic urticaria (CIU), or hives of unknown cause, in adults and children 6 years of age and older. The tablet disintegrates orally, is taken once-daily for 24-hour relief, and now comes in a new "tutti frutti" flavor. ...